Clinical Trial Update: Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)

View source ↗

Summary

This clinical trial update reports on the efficacy of rosuvastatin in untreated high-risk patients in daily practice (CHALLENGE), with the study now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disease
• Coronary Heart Disease
• Diabetes Mellitus
• Hypercholesterolemia
• Peripheral Vascular Disease

Drugs mentioned

• Rosuvastatin (Crestor) (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Hypercholesterolemia, Coronary Heart Disease | Status: COMPLETED